Cargando…

Immune Effects of Corticosteroids in Sepsis

Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies...

Descripción completa

Detalles Bibliográficos
Autores principales: Heming, Nicholas, Sivanandamoorthy, Sivanthiny, Meng, Paris, Bounab, Rania, Annane, Djillali
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077259/
https://www.ncbi.nlm.nih.gov/pubmed/30105022
http://dx.doi.org/10.3389/fimmu.2018.01736
_version_ 1783344873287450624
author Heming, Nicholas
Sivanandamoorthy, Sivanthiny
Meng, Paris
Bounab, Rania
Annane, Djillali
author_facet Heming, Nicholas
Sivanandamoorthy, Sivanthiny
Meng, Paris
Bounab, Rania
Annane, Djillali
author_sort Heming, Nicholas
collection PubMed
description Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies on source control and organ support. Septic shock, the most severe form of sepsis is associated with the highest rate of mortality. Two large multicentre trials, undertaken 15 years apart, found that the combination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock. The corticosteroids family is composed of several molecules that are usually characterized according to their glucocorticoid and mineralocorticoid power, relative to hydrocortisone. While the immune effects of glucocorticoids whether mediated or not by the intracellular glucocorticoid receptor have been investigated for several decades, it is only very recently that potential immune effects of mineralocorticoids via non-renal mineralocorticoid receptors have gained popularity. We reviewed the respective role of glucocorticoids and mineralocorticoids in counteracting sepsis-associated dysregulated immune systems.
format Online
Article
Text
id pubmed-6077259
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-60772592018-08-13 Immune Effects of Corticosteroids in Sepsis Heming, Nicholas Sivanandamoorthy, Sivanthiny Meng, Paris Bounab, Rania Annane, Djillali Front Immunol Immunology Sepsis, a life-threatening organ dysfunction, results from a dysregulated host response to invading pathogens that may be characterized by overwhelming systemic inflammation or some sort of immune paralysis. Sepsis remains a major cause of morbidity and mortality. Treatment is nonspecific and relies on source control and organ support. Septic shock, the most severe form of sepsis is associated with the highest rate of mortality. Two large multicentre trials, undertaken 15 years apart, found that the combination of hydrocortisone and fludrocortisone significantly reduces mortality in septic shock. The corticosteroids family is composed of several molecules that are usually characterized according to their glucocorticoid and mineralocorticoid power, relative to hydrocortisone. While the immune effects of glucocorticoids whether mediated or not by the intracellular glucocorticoid receptor have been investigated for several decades, it is only very recently that potential immune effects of mineralocorticoids via non-renal mineralocorticoid receptors have gained popularity. We reviewed the respective role of glucocorticoids and mineralocorticoids in counteracting sepsis-associated dysregulated immune systems. Frontiers Media S.A. 2018-07-30 /pmc/articles/PMC6077259/ /pubmed/30105022 http://dx.doi.org/10.3389/fimmu.2018.01736 Text en Copyright © 2018 Heming, Sivanandamoorthy, Meng, Bounab and Annane. https://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Immunology
Heming, Nicholas
Sivanandamoorthy, Sivanthiny
Meng, Paris
Bounab, Rania
Annane, Djillali
Immune Effects of Corticosteroids in Sepsis
title Immune Effects of Corticosteroids in Sepsis
title_full Immune Effects of Corticosteroids in Sepsis
title_fullStr Immune Effects of Corticosteroids in Sepsis
title_full_unstemmed Immune Effects of Corticosteroids in Sepsis
title_short Immune Effects of Corticosteroids in Sepsis
title_sort immune effects of corticosteroids in sepsis
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6077259/
https://www.ncbi.nlm.nih.gov/pubmed/30105022
http://dx.doi.org/10.3389/fimmu.2018.01736
work_keys_str_mv AT hemingnicholas immuneeffectsofcorticosteroidsinsepsis
AT sivanandamoorthysivanthiny immuneeffectsofcorticosteroidsinsepsis
AT mengparis immuneeffectsofcorticosteroidsinsepsis
AT bounabrania immuneeffectsofcorticosteroidsinsepsis
AT annanedjillali immuneeffectsofcorticosteroidsinsepsis